| Product Information |
|
| Registration Number |
BR-1406
|
| Generic Name |
Insulin Aspart
|
| Brand Name |
Fiasp
|
| Dosage Strength |
100 Units (equivalent to 3.5 mg)/mL
|
| Dosage Form |
Solution for
Injection (IV/SC)
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
Antidiabetics
|
| Packaging |
10 mL Type I glass vial with bromobutyl rubber stopper and aluminum flip-off cap (Box of 1's)
|
| Manufacturer |
Novo Nordisk Pharmaceutical Industries, LP
|
| Country of Origin |
United States of America
|
| Trader |
N/A
|
| Importer |
Novo Nordisk Pharmaceuticals (Philippines), Inc.
|
| Distributor |
Novo Nordisk Pharmaceuticals (Philippines), Inc.
|
| Application Type |
Initial
|
| Issuance Date |
14 July 2022
|
| Expiry Date |
14 July 2027
|